George Brady

Matheson LLP - Ireland


+353 1 232 2027

Highly regarded

Bar admissions:

New York



Practice areas:

Capital markets : Equity
Private equity

George is a partner in the firm's Corporate Department.

He has advised on many of the most significant Irish corporate transactions of recent years including:

  • Allergan’s $66 billion merger with Actavis;
  • unsuccesful bid to acquire eircom from examinership on behalf of an international telecommunications group;
  • the Actavis $8.5 billion acquisition of Warner Chilcott;
  • the $6.5 billion hostile bid by Royalty Pharma for Elan Corporation;
  • Medtronic’s proposed $42.9 billion acquisition of Covidien plc;
  • Eaton Corporation’s $11.8 billion acquisition of Cooper Industries;
  • the $5.6 billion merger of Questcor and Mallinckrodt;
  • Babcock & Brown on its €2.3 billion acquisition of eircom; and
  • the $2.6 billion acquisition of Auxilium Pharmaceuticals by Endo International.

George previously worked in the London office of a leading international law firm and has been a partner since 2003.